Phreesia, Inc. (PHR)
NYSE: PHR · IEX Real-Time Price · USD
20.50
-0.17 (-0.82%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Phreesia Market Cap
Phreesia has a market cap or net worth of $1.18 billion as of July 2, 2024. Its market cap has decreased by -27.79% in one year.
Market Cap
1.18B
Enterprise Value
1.11B
1-Year Change
-27.79%
Ranking
Category
Stock Price
$20.50
Market Cap Chart
Since July 18, 2019, Phreesia's market cap has increased from $882.50M to $1.18B, an increase of 33.33%. That is a compound annual growth rate of 5.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.19B | -7.88% |
| Dec 29, 2023 | 1.29B | -24.55% |
| Dec 30, 2022 | 1.71B | -20.04% |
| Dec 31, 2021 | 2.13B | -10.92% |
| Dec 31, 2020 | 2.40B | 150.66% |
| Dec 31, 2019 | 956.00M | 8.33% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Omnicell | 1.22B |
| Sana Biotechnology | 1.21B |
| Longboard Pharmaceuticals | 1.20B |
| Establishment Labs Holdings | 1.19B |
| Day One Biopharmaceuticals | 1.19B |
| Xencor | 1.17B |
| Arcutis Biotherapeutics | 1.11B |
| 4D Molecular Therapeutics | 1.10B |